• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定新型生物标志物以区分缓激肽介导的血管性水肿与肥大细胞/组胺介导的血管性水肿。

Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedema.

机构信息

Department of Dermatology and Allergy, Hannover Medical School, Comprehensive Allergy Center, Hereditary Angioedema center for rare diseases, Hannover, Germany.

Department of Dermatology, Venerology and Allergology, University Medical Centre Göttingen, Göttingen, Germany.

出版信息

Allergy. 2022 Mar;77(3):946-955. doi: 10.1111/all.15013. Epub 2021 Jul 28.

DOI:10.1111/all.15013
PMID:34287950
Abstract

BACKGROUND

The pathophysiology of the underlying paroxysmal permeability disturbances in angioedema (AE) is not well understood.

METHODS

To identify clinical and laboratory parameters specific for a certain AE subtype, 40 AE patients were prospectively enrolled: 15 hereditary (HAE), 13 ACE-inhibitor induced (ACE-AE), and 12 mast cell-mediated without wheals in chronic spontaneous urticaria (CSU-AE). Ten healthy subjects served as controls. Serum levels of markers indicating activation of the ficolin-lectin pathway, of endothelial cells, or those indicating impairment of vascular integrity or inflammation were assessed by enzyme-linked immunosorbent assay.

RESULTS

New routine clinical diagnostic criteria could not be identified, not even for distinguishing bradykinin-mediated (BK-) AE (ie, HAE and ACE-AE) from mast cell-/histamine-mediated CSU-AE. However, FAP-α and tPA were significantly increased in all AE compared to controls. In HAE, FAP- α, tPA, uPAR, pentraxin-3, Tie-2, sE-selectin, and VE-cadherin were significantly increased compared to controls. In HAE compared to CSU-AE and ACE-AE, sE-Selectin, Tie-2, and VE-Cadherin were significantly increased, whereas for Ang-2 the difference was significant compared to CSU-AE only. Tie-2 correlated strongly negatively with C4, C1-INH activity, and C1-INH function.

CONCLUSIONS

This study is the first to compare HAE, ACE-AE, and CSU-AE. Although significance is limited by small sample size, Tie-2 was identified as a new promising biomarker candidate for HAE. FAP- α and tPA might serve as a marker for AE in general, whereas sE-selectin and Ang-2 were increased in BK-AE only. Our results add information to the role of endothelial dysfunction and serine proteases in different AE subtypes.

摘要

背景

血管性水肿(AE)潜在阵发性通透性紊乱的病理生理学尚未完全了解。

方法

为了确定特定 AE 亚型的临床和实验室参数,前瞻性纳入 40 名 AE 患者:15 名遗传性血管性水肿(HAE)、13 名血管紧张素转换酶抑制剂诱导的血管性水肿(ACE-AE)和 12 名慢性自发性荨麻疹中无风团的肥大细胞介导的血管性水肿(CSU-AE)。10 名健康受试者作为对照。通过酶联免疫吸附试验评估指示纤维胶凝素-凝集素途径、内皮细胞激活或血管完整性或炎症受损的标志物的血清水平。

结果

甚至无法确定新的常规临床诊断标准,甚至无法区分缓激肽介导的(BK-)AE(即 HAE 和 ACE-AE)与肥大细胞/组胺介导的 CSU-AE。然而,与对照组相比,所有 AE 患者的 FAP-α 和 tPA 均显着增加。与对照组相比,在 HAE 中,FAP-α、tPA、uPAR、Pentraxin-3、Tie-2、sE-选择素和 VE-钙粘蛋白显着增加。与 CSU-AE 和 ACE-AE 相比,HAE 患者 sE-选择素、Tie-2 和 VE-钙粘蛋白显着增加,而与 CSU-AE 相比,Ang-2 的差异仅显着。Tie-2 与 C4、C1-INH 活性和 C1-INH 功能呈强烈负相关。

结论

这项研究是首次比较 HAE、ACE-AE 和 CSU-AE。尽管由于样本量小,意义有限,但 Tie-2 被确定为 HAE 的一种有前途的新生物标志物候选物。FAP-α 和 tPA 可能作为 AE 的一般标志物,而 sE-选择素和 Ang-2 仅在 BK-AE 中增加。我们的结果为不同 AE 亚型中内皮功能障碍和丝氨酸蛋白酶的作用提供了信息。

相似文献

1
Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedema.鉴定新型生物标志物以区分缓激肽介导的血管性水肿与肥大细胞/组胺介导的血管性水肿。
Allergy. 2022 Mar;77(3):946-955. doi: 10.1111/all.15013. Epub 2021 Jul 28.
2
Angioedema Without Wheals: Challenges in Laboratorial Diagnosis.无风团性血管性水肿:实验室诊断的挑战。
Front Immunol. 2021 Dec 8;12:785736. doi: 10.3389/fimmu.2021.785736. eCollection 2021.
3
Recognition and Differential Diagnosis of Hereditary Angioedema in the Emergency Department.急诊科遗传性血管性水肿的识别与鉴别诊断。
J Emerg Med. 2021 Jan;60(1):35-43. doi: 10.1016/j.jemermed.2020.09.044. Epub 2020 Nov 17.
4
Clinical Features of Hereditary and Mast Cell-mediated Angioedema Focusing on the Differential Diagnosis in Japanese Patients.遗传性和肥大细胞介导的血管性水肿的临床特征:聚焦于日本患者的鉴别诊断
Intern Med. 2018 Feb 1;57(3):319-324. doi: 10.2169/internalmedicine.8624-16. Epub 2017 Nov 1.
5
Towards a specific marker for acute bradykinin-mediated angioedema attacks: a literature review.寻找急性缓激肽介导的血管性水肿发作的特异性标志物:文献综述
Eur J Dermatol. 2015 Jul-Aug;25(4):290-5. doi: 10.1684/ejd.2015.2547.
6
Urticaria and Angioedema: Understanding Complex Pathomechanisms to Facilitate Patient Communication, Disease Management, and Future Treatment.荨麻疹和血管性水肿:理解复杂的发病机制以促进医患沟通、疾病管理及未来治疗
J Allergy Clin Immunol Pract. 2023 Jan;11(1):94-106. doi: 10.1016/j.jaip.2022.11.006.
7
Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.遗传性和获得性C1抑制物依赖性血管性水肿:从病理生理学到治疗
Ann Med. 2016;48(4):256-67. doi: 10.3109/07853890.2016.1162909. Epub 2016 Mar 26.
8
Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.缓激肽介导的血管性水肿的流行病学:对流行病学研究的系统调查。
Orphanet J Rare Dis. 2018 May 4;13(1):73. doi: 10.1186/s13023-018-0815-5.
9
Clinical and laboratory characteristics that differentiate hereditary angioedema in 72 patients with angioedema.72例血管性水肿患者中区分遗传性血管性水肿的临床和实验室特征
Allergol Int. 2014 Dec;63(4):595-602. doi: 10.2332/allergolint.14-OA-0700.
10
Evidence for bradykinin release in chronic spontaneous urticaria.慢性自发性荨麻疹中缓激肽释放的证据。
Clin Exp Allergy. 2020 Mar;50(3):343-351. doi: 10.1111/cea.13558. Epub 2020 Jan 21.

引用本文的文献

1
Activation of the Complement/Lectin Pathway, Angiopoietin/Tie-2/VEGF-System, Cytokines and Chemokines in Different Angioedema Subtypes.不同血管性水肿亚型中补体/凝集素途径、血管生成素/Tie-2/血管内皮生长因子系统、细胞因子和趋化因子的激活
Eur J Immunol. 2025 Jul;55(7):e70010. doi: 10.1002/eji.70010.
2
Hereditary angioedema plasma proteomics following specific plasma kallikrein inhibition with lanadelumab.使用拉那度单抗特异性抑制血浆激肽释放酶后遗传性血管性水肿的血浆蛋白质组学
Front Immunol. 2025 May 9;15:1471168. doi: 10.3389/fimmu.2024.1471168. eCollection 2024.
3
Systemic inflammation biomarkers during angioedema attacks in hereditary angioedema.
遗传性血管性水肿发作期间的全身性炎症生物标志物。
Front Immunol. 2024 Jun 17;15:1400526. doi: 10.3389/fimmu.2024.1400526. eCollection 2024.
4
Five-Membered Nitrogen Heterocycles Angiotensin-Converting Enzyme (ACE) Inhibitors Induced Angioedema: An Underdiagnosed Condition.五元氮杂环类血管紧张素转换酶(ACE)抑制剂诱发的血管性水肿:一种诊断不足的病症。
Pharmaceuticals (Basel). 2024 Mar 10;17(3):360. doi: 10.3390/ph17030360.
5
The Occurrence of Atopy in Patients with Isolated Spontaneous Mast Cell (or Nonallergic) Angioedema.孤立性自发性肥大细胞(或非过敏性)血管性水肿患者特应性的发生情况。
J Clin Med. 2024 Jan 15;13(2):477. doi: 10.3390/jcm13020477.
6
Patient-rated angioedema severity using a novel photo-aid for predicting non-mast cell mediator-induced angioedema diagnosis.使用一种新型照片辅助工具评估患者自评的血管性水肿严重程度,以预测非肥大细胞介质诱导的血管性水肿诊断。
World Allergy Organ J. 2023 Jun 27;16(6):100784. doi: 10.1016/j.waojou.2023.100784. eCollection 2023 Jun.
7
Genetic Variants Leading to Urticaria and Angioedema and Associated Biomarkers.导致荨麻疹和血管性水肿的遗传变异及其相关生物标志物。
J Allergy Clin Immunol Pract. 2023 Aug;11(8):2286-2301. doi: 10.1016/j.jaip.2023.05.031. Epub 2023 May 30.
8
Acquired Angioedema in Selected Neoplastic Diseases.某些肿瘤性疾病相关获得性血管性水肿。
Medicina (Kaunas). 2023 Mar 24;59(4):644. doi: 10.3390/medicina59040644.
9
PLAUR splicing pattern in hereditary angioedema patients' monocytes and macrophages.PLAUR 在遗传性血管性水肿患者单核细胞和巨噬细胞中的剪接模式。
Mol Biol Rep. 2023 Jun;50(6):4975-4982. doi: 10.1007/s11033-023-08391-8. Epub 2023 Apr 22.
10
Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation.遗传性血管性水肿:过度接触激活的临床表现。
Semin Thromb Hemost. 2024 Oct;50(7):978-988. doi: 10.1055/s-0042-1758820. Epub 2022 Nov 23.